Cargando…

Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †

SIMPLE SUMMARY: Surgery is generally the treatment of choice for locoregional recurrences of well-differentiated thyroid carcinomas, but other therapies can be considered on an individual basis. These patients are expected to have prolonged survival, even with the possibility of long periods of acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalheiro, Beatriz G., Shah, Jatin P., Randolph, Gregory W., Medina, Jesus E., Tufano, Ralph P., Zafereo, Mark, Hartl, Dana M., Nixon, Iain J., Guntinas-Lichius, Orlando, Vander Poorten, Vincent, López, Fernando, Khafif, Avi Hefetz, Owen, Randall P., Shaha, Ashok, Rodrigo, Juan P., Rinaldo, Alessandra, Mäkitie, Antti A., Silver, Carl E., Sanabria, Alvaro, Kowalski, Luiz P., Ferlito, Alfio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913047/
https://www.ncbi.nlm.nih.gov/pubmed/36765880
http://dx.doi.org/10.3390/cancers15030923
_version_ 1784885333585821696
author Cavalheiro, Beatriz G.
Shah, Jatin P.
Randolph, Gregory W.
Medina, Jesus E.
Tufano, Ralph P.
Zafereo, Mark
Hartl, Dana M.
Nixon, Iain J.
Guntinas-Lichius, Orlando
Vander Poorten, Vincent
López, Fernando
Khafif, Avi Hefetz
Owen, Randall P.
Shaha, Ashok
Rodrigo, Juan P.
Rinaldo, Alessandra
Mäkitie, Antti A.
Silver, Carl E.
Sanabria, Alvaro
Kowalski, Luiz P.
Ferlito, Alfio
author_facet Cavalheiro, Beatriz G.
Shah, Jatin P.
Randolph, Gregory W.
Medina, Jesus E.
Tufano, Ralph P.
Zafereo, Mark
Hartl, Dana M.
Nixon, Iain J.
Guntinas-Lichius, Orlando
Vander Poorten, Vincent
López, Fernando
Khafif, Avi Hefetz
Owen, Randall P.
Shaha, Ashok
Rodrigo, Juan P.
Rinaldo, Alessandra
Mäkitie, Antti A.
Silver, Carl E.
Sanabria, Alvaro
Kowalski, Luiz P.
Ferlito, Alfio
author_sort Cavalheiro, Beatriz G.
collection PubMed
description SIMPLE SUMMARY: Surgery is generally the treatment of choice for locoregional recurrences of well-differentiated thyroid carcinomas, but other therapies can be considered on an individual basis. These patients are expected to have prolonged survival, even with the possibility of long periods of active disease and the need for subsequent treatments. The present review intends to provide considerations regarding these therapeutic possibilities. ABSTRACT: Surgery has been historically the preferred primary treatment for patients with well-differentiated thyroid carcinoma and for selected locoregional recurrences. Adjuvant therapy with radioactive iodine is typically recommended for patients with an intermediate to high risk of recurrence. Despite these treatments, locally advanced disease and locoregional relapses are not infrequent. These patients have a prolonged overall survival that may result in long periods of active disease and the possibility of requiring subsequent treatments. Recently, many new options have emerged as salvage therapies. This review offers a comprehensive discussion and considerations regarding surgery, active surveillance, radioactive iodine therapy, ultrasonography-guided percutaneous ablation, external beam radiotherapy, and systemic therapy for well-differentiated thyroid cancer based on relevant publications and current reference guidelines. We feel that the surgical member of the thyroid cancer management team is empowered by being aware and facile with all management options.
format Online
Article
Text
id pubmed-9913047
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99130472023-02-11 Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review † Cavalheiro, Beatriz G. Shah, Jatin P. Randolph, Gregory W. Medina, Jesus E. Tufano, Ralph P. Zafereo, Mark Hartl, Dana M. Nixon, Iain J. Guntinas-Lichius, Orlando Vander Poorten, Vincent López, Fernando Khafif, Avi Hefetz Owen, Randall P. Shaha, Ashok Rodrigo, Juan P. Rinaldo, Alessandra Mäkitie, Antti A. Silver, Carl E. Sanabria, Alvaro Kowalski, Luiz P. Ferlito, Alfio Cancers (Basel) Review SIMPLE SUMMARY: Surgery is generally the treatment of choice for locoregional recurrences of well-differentiated thyroid carcinomas, but other therapies can be considered on an individual basis. These patients are expected to have prolonged survival, even with the possibility of long periods of active disease and the need for subsequent treatments. The present review intends to provide considerations regarding these therapeutic possibilities. ABSTRACT: Surgery has been historically the preferred primary treatment for patients with well-differentiated thyroid carcinoma and for selected locoregional recurrences. Adjuvant therapy with radioactive iodine is typically recommended for patients with an intermediate to high risk of recurrence. Despite these treatments, locally advanced disease and locoregional relapses are not infrequent. These patients have a prolonged overall survival that may result in long periods of active disease and the possibility of requiring subsequent treatments. Recently, many new options have emerged as salvage therapies. This review offers a comprehensive discussion and considerations regarding surgery, active surveillance, radioactive iodine therapy, ultrasonography-guided percutaneous ablation, external beam radiotherapy, and systemic therapy for well-differentiated thyroid cancer based on relevant publications and current reference guidelines. We feel that the surgical member of the thyroid cancer management team is empowered by being aware and facile with all management options. MDPI 2023-02-01 /pmc/articles/PMC9913047/ /pubmed/36765880 http://dx.doi.org/10.3390/cancers15030923 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cavalheiro, Beatriz G.
Shah, Jatin P.
Randolph, Gregory W.
Medina, Jesus E.
Tufano, Ralph P.
Zafereo, Mark
Hartl, Dana M.
Nixon, Iain J.
Guntinas-Lichius, Orlando
Vander Poorten, Vincent
López, Fernando
Khafif, Avi Hefetz
Owen, Randall P.
Shaha, Ashok
Rodrigo, Juan P.
Rinaldo, Alessandra
Mäkitie, Antti A.
Silver, Carl E.
Sanabria, Alvaro
Kowalski, Luiz P.
Ferlito, Alfio
Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
title Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
title_full Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
title_fullStr Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
title_full_unstemmed Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
title_short Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
title_sort management of recurrent well-differentiated thyroid carcinoma in the neck: a comprehensive review †
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913047/
https://www.ncbi.nlm.nih.gov/pubmed/36765880
http://dx.doi.org/10.3390/cancers15030923
work_keys_str_mv AT cavalheirobeatrizg managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT shahjatinp managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT randolphgregoryw managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT medinajesuse managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT tufanoralphp managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT zafereomark managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT hartldanam managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT nixoniainj managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT guntinaslichiusorlando managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT vanderpoortenvincent managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT lopezfernando managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT khafifavihefetz managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT owenrandallp managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT shahaashok managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT rodrigojuanp managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT rinaldoalessandra managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT makitieanttia managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT silvercarle managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT sanabriaalvaro managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT kowalskiluizp managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview
AT ferlitoalfio managementofrecurrentwelldifferentiatedthyroidcarcinomaintheneckacomprehensivereview